Literature DB >> 11316946

Reduced PO(2) and adenosine formation preserve arteriolar nitric oxide synthesis during sympathetic constriction in the rat intestine.

B A Sauls1, M A Boegehold.   

Abstract

Previous reports by this laboratory have indicated that a flow-dependent fall in arteriolar wall PO(2 )may be a stimulus for the sustained release of endothelial nitric oxide (NO) during sympathetic vasoconstriction in the superfused rat intestine. In this study, we tested the hypothesis that locally formed adenosine serves as the link between the fall in local PO(2) and NO synthesis under these conditions. Adenosine applied via pressurized micropipettes directly onto the wall or at a distance of 25 microm from the wall of first-order arterioles (resting diameter = 54 +/- 1 microm) elicited dose-dependent dilations of 15-46% that were significantly reduced by the NO synthase inhibitor N(G)-monomethyl-L-arginine (L-NMMA, 10(-4) M). Arteriolar responses to sympathetic nerve stimulation were enhanced by 57-66% in the presence of L-NMMA or when tissue PO(2) was prevented from falling under a high O(2) superfusate. Adenosine deaminase (2.0 U/ml) or the selective A(1) receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (4 x 10(-4) M) completely blocked the enhancing effect of L-NMMA on sympathetic constriction. These results are consistent with the hypothesis that the fall in arteriolar wall and/or tissue PO(2) that accompanies sympathetic arteriolar constriction in the rat intestine can lead to local adenosine production, which in turn preserves endothelial NO release.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11316946     DOI: 10.1159/000051037

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  1 in total

1.  Influence of endogenous nitric oxide on sympathetic vasoconstriction in normoxia, acute and chronic systemic hypoxia in the rat.

Authors:  Andrew M Coney; Mark Bishay; Janice M Marshall
Journal:  J Physiol       Date:  2004-01-14       Impact factor: 5.182

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.